Mariposa Therapeutics

Mariposa Therapeutics is a pioneering biotechnology company dedicated to developing innovative solutions for patients, particularly those suffering from epidermolysis bullosa simplex (EBS). Located in Abertillery, Wales, at Roseheyworth Business Park, Unit G-H, Abertillery, Wales NP13 1SX, GB, Mariposa Therapeutics is focused on healing wounds that go beyond skin deep through groundbreaking research and development.

At the heart of Mariposa Therapeutics' approach is its unique expertise in ajoene chemistry. The company's first solution, derived from the unique chemistry and biological activity of ajoene (a metabolite of crushed garlic), offers a novel pathway to address the challenges of EBS. Mariposa Therapeutics has identified synthetic analogues of this small molecule that activate surrogate keratin expression, functionally compensating for the genetic defect in EB simplex patients.

With a commitment to improving patient outcomes and quality of life, Mariposa Therapeutics continues to advance its research and expand its portfolio of therapeutic solutions. The company is driven by a passion for scientific innovation and a dedication to making a meaningful difference in the lives of those affected by challenging medical conditions. We invite the management of Mariposa Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional work.